1-3 of 3
Pablo Cagnoni
Close
Sort by
Journal Articles

PROPEL: A Multi-Center Phase 2 Open-Label Study of Pralatrexate (PDX) with Vitamin B 12 and Folic Acid Supplementation in Patients with Replapsed or Refractory Peripheral T-Cell Lymphoma

Owen A. O’Connor, MD, PhD, Barbara Pro, M.D., Lauren Pinter-Brown, MD, Leslie Popplewell, MD, Nancy Barlett, MD, Andrei Shustov, MD, Mary Jo Lechowicz, MD, Kerry J Savage, MD, MSc, Bertrand Coiffier, MD, Eric Jacobsen, MD, Pier Luigi Zinzani, MD, Andre Goy, MD, Jasmine Zain, MD, Shannon Wilroy, Molly Patterson, Adam Boyd, Michael E. Saunders, MD, Pablo Cagnoni, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2008) 112 (11): 261.
https://doi.org/10.1182/blood.V112.11.261.261
Published: 2008
Journal Articles

Pralatrexate (PDX) IS Active in Cutaneous T-Cell Lymphoma: Preliminary Results of a Multi-Center Dose-Finding Trial.

Steven M. Horwitz, MD, Madeleine Duvic, MD, Youn Kim, MD, Jasmine M. Zain, MD, Mary Jo Lechowicz, MD, Patricia Myskowski, MD, Hanna Weissbrot, Danielle Wright, Lacey Chance, Tony Koutsoukos, Pablo Cagnoni, MD, Michael Saunders, MD, Owen A. O’Connor, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1569.
https://doi.org/10.1182/blood.V112.11.1569.1569
Published: 2008
Journal Articles

Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer

Clinical Trials & Observations
Ian McNiece, Roy Jones, Scott I. Bearman, Pablo Cagnoni, Yago Nieto, Wilbur Franklin, John Ryder, Andrea Steele, Judy Stoltz, Peggy Russell, Janet McDermitt, Christopher Hogan, James Murphy, Elizabeth J. Shpall
Journal: Blood
Blood (2000) 96 (9): 3001–3007.
https://doi.org/10.1182/blood.V96.9.3001
Published: 2000